North West Skincare Ltd - Period Ending 2021-10-31

North West Skincare Ltd - Period Ending 2021-10-31


North West Skincare Ltd 07302484 false 2020-11-01 2021-10-31 2021-10-31 The principal activity of the company is private dermatologist practice Digita Accounts Production Advanced 6.30.9574.0 true 07302484 2020-11-01 2021-10-31 07302484 2021-10-31 07302484 core:CurrentFinancialInstruments core:WithinOneYear 2021-10-31 07302484 bus:Micro-entities 2020-11-01 2021-10-31 07302484 bus:AuditExemptWithAccountantsReport 2020-11-01 2021-10-31 07302484 bus:FullAccounts 2020-11-01 2021-10-31 07302484 bus:SmallCompaniesRegimeForAccounts 2020-11-01 2021-10-31 07302484 bus:RegisteredOffice 2020-11-01 2021-10-31 07302484 bus:Director1 2020-11-01 2021-10-31 07302484 bus:Director2 2020-11-01 2021-10-31 07302484 bus:PrivateLimitedCompanyLtd 2020-11-01 2021-10-31 07302484 countries:England 2020-11-01 2021-10-31 07302484 2019-11-01 2020-10-31 07302484 2020-10-31 07302484 core:CurrentFinancialInstruments core:WithinOneYear 2020-10-31 07302484 core:RestatedAmount 2020-10-31 iso4217:GBP xbrli:pure

Registration number: 07302484

North West Skincare Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 31 October 2021

 

North West Skincare Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

North West Skincare Ltd

Company Information

Directors

Dr John Thomas Lear

Dr. Mary Theresa Atherton

Registered office

3 Crewe Road
Sandbach
Cheshire
CW11 4NE

 

North West Skincare Ltd

(Registration number: 07302484)
Balance Sheet as at 31 October 2021

2021
£

(As restated)

2020
£

Fixed assets

204,956

202,978

Current assets

593,472

390,539

Prepayments and accrued income

2,491

2,760

Creditors: Amounts falling due within one year

(89,430)

(45,000)

Net current assets

506,533

348,299

Total assets less current liabilities

711,489

551,277

Accruals and deferred income

(2,940)

(3,046)

 

708,549

548,231

Capital and reserves

708,549

548,231

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
3 Crewe Road
Sandbach
Cheshire
CW11 4NE
United Kingdom

These financial statements were authorised for issue by the Board on 24 May 2022.

Basis of preparation

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2020 - 2).

3

Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The total amount of financial commitments not included in the balance sheet is £6,175 (2020 - £12,350).

The nature of the financial commitments is that of a contract hire agreement of which there is a 12 month term remaining as at the balance sheet date.

 

North West Skincare Ltd

(Registration number: 07302484)
Balance Sheet as at 31 October 2021

For the financial year ending 31 October 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved and authorised by the Board on 24 May 2022 and signed on its behalf by:
 

.........................................
Dr John Thomas Lear
Director

.........................................
Dr. Mary Theresa Atherton
Director